Fig. 3: Mutational profile of accelerated phase (AP-CML) and blast phase (BP-CML) CML.
From: Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia
A Distribution of mutations in patients with AP-CML, and B BP-CML. C Association between non-ABL1 gene mutations and the blast phase phenotype.
